Emster Kurt von

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Herb Cross, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Emster Kurt von

Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
2,960,231
Estimated value
$53,284,158
Report date
18 May 2021
Price
$18.00
Ownership
Indirect
Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
17,828
Estimated value
$320,904
Report date
17 May 2021
Price
$18.00
Ownership
Direct
Form 4 holding Director

Vaxcyte, Inc.

Security class
Stock option (right to buy)
Shares / value
15,000
Estimated value
Report date
02 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock, $0.001 par value per share
Underlying amount
Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
9,925
Estimated value
Report date
13 May 2021
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

CymaBay Therapeutics, Inc.

Security class
Stock Appreciation Right
Shares / value
0
Estimated value
Report date
29 Sep 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CymaBay Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
22 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
18 May 2021
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Emster Kurt von

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .